Healthcare Analyst Steinhardt hosts a doctor Analyst/Industry conference call relevant to Glaukos (GKOS) on December 18.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GKOS:
- Glaukos price target raised to $125 from $113 at Citi
- Glaukos price target raised to $125 from $117 at Needham
- Positive Outlook for Glaukos: Buy Rating Reinforced by Epioxa’s Market Potential and Increased Price Target
- Glaukos Highlights Innovation in November 2025 Presentation
- Beaten Down by 35%-Plus: Analysts Say These 2 Oversold Stocks Are Poised to Turn the Corner